Medytoks "Court Suspends Enforcement of Sales Ban on Medytoxin Injection"
[Asia Economy Reporter Geum Bo-ryeong] Medytox announced on the 22nd that the appellate court upheld the appeal result in the provisional injunction case against the provisional manufacturing and sales suspension order.
Hot Picks Today
"Buy on Black Monday"... Japan's Nomura Forecasts 590,000 for Samsung, 4 Million for SK hynix
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- "We're Now Earning 10 Million Won a Month"... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- 'Bond King' Gundlach: "Rate Cuts Impossible... CPI Could Rise to 4%"
- Experts Are Already Watching Closely..."Target Stock Price 970,000 Won" Now Only the Uptrend Remains [Weekend Money]
Medytox had filed a provisional injunction application with the Daejeon District Court against the provisional manufacturing and sales suspension order for Meditoxin 100-unit products issued by the Daejeon Regional Food and Drug Administration, but it was dismissed, leading them to appeal to the Daejeon High Court. As a result, the first trial decision was overturned and the appeal was accepted.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
